|
HIGD1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.703500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.325500E-02 |
| Normal-vs-Stage2 |
1.030070E-02 |
| Normal-vs-Stage3 |
3.259800E-03 |
| Normal-vs-Stage4 |
3.848300E-04 |
| Stage1-vs-Stage2 |
4.806000E-01 |
| Stage1-vs-Stage3 |
2.009000E-01 |
| Stage1-vs-Stage4 |
9.456300E-03 |
| Stage2-vs-Stage3 |
6.799000E-01 |
| Stage2-vs-Stage4 |
1.124040E-01 |
| Stage3-vs-Stage4 |
2.941000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.342000E-03 |
| Normal-vs-AfricanAmerican |
2.133800E-01 |
| Normal-vs-Asian |
1.443030E-01 |
| Caucasian-vs-AfricanAmerican |
1.492750E-01 |
| Caucasian-vs-Asian |
9.956600E-01 |
| AfricanAmerican-vs-Asian |
6.325000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.604000E-03 |
| Normal-vs-Female |
1.037420E-01 |
| Male-vs-Female |
1.067580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.843500E-02 |
| Normal-vs-Extreme_Weight |
2.864600E-03 |
| Normal-vs-Obese |
2.978300E-03 |
| Normal-vs-Extreme_Obese |
4.383800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.100200E-01 |
| Normal_Weight-vs-Obese |
7.904400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.501800E-01 |
| Extreme_Weight-vs-Obese |
8.686000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.517000E-01 |
| Obese-vs-Extreme_Obese |
6.131800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.039600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.119320E-03 |
| Normal-vs-Age(61-80Yrs) |
1.688110E-02 |
| Normal-vs-Age(81-100Yrs) |
5.541700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.927200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.035000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.704600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.868400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.876200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.964600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.342700E-03 |
| Normal-VS-Type2 PRCC |
6.14089999999567E-05 |
| Normal-VS-KIRP CIMP |
5.677800E-01 |
| Normal-VS-Unclassified PRCC |
6.376100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.221900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.417800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.407200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.557500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.112200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.916200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.10480000000835E-05 |
| Normal-vs-N1 |
1.84129999999394E-05 |
| Normal-vs-N2 |
7.420600E-03 |
| N0-vs-N1 |
3.894200E-01 |
| N0-vs-N2 |
3.248600E-01 |
| N1-vs-N2 |
4.634400E-01 |
|
|
